New Drug Safety Evaluation and Research Center Receives GLP Certification by CFDA

Release date:2015-12-18  Release:

December 9, CPU New Drug Safety Evaluation and Research Center (hereinafter referred to as the Safety Evaluation Center) wins CFDA drugs GLP certification.

The safety evaluation center was founded in 2009, constructed and equipped since 2013 and received CFDA evaluation in October 27 to 31, 2015.

Currently the safety evaluation center undertakes single and multiple dose toxicity tests (rodent), single and multiple dose toxicity study (non-rodent), genotoxicity tests (Ames, micronucleus, chromosomal aberrations), local toxicity test, reproductive toxicity, immunogenicity test, toxicokinetic tests and safety pharmacology tests.The center is the most comprehensive GLP organization dedicated to serve universities and pharmaceutical companies.